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Objectives: Young adults are essential to the effective mitigation of the novel coronavirus
(SARS-CoV-2/COVID-19) given their tendency toward greater frequency of social
interactions. Little is known about vaccine willingness during pandemics in European
populations. This study examined young people’s attitudes toward COVID-19 vaccines in
Fall 2020.
Methods: Data came from an ongoing longitudinal study’s online COVID-19-focused
supplement among young adults aged 22 in Zurich, Switzerland (N  499) in September
2020. Logistic regressions examined young adults’ likelihood of participating in COVID-19
immunization programs.
Results: Approximately half of respondents reported being unlikely to get vaccinated
against COVID-19. Compared to males, females were more likely to oppose COVID-19
vaccination (p < 0.05). In multivariate models, Sri Lankan maternal background and higher
socioeconomic status were associated with a greater likelihood of getting vaccinated
against COVID-19 (p < 0.05). Respondents were more likely to report a willingness to get
vaccinated against COVID-19 when they perceived 1) an effective government response
(p < 0.05) and 2) their information sources to be objective (p < 0.05).
Conclusion: This study communicates aspects important to the development of targeted
information campaigns to promote engagement in COVID-19 immunization efforts.
Keywords: vaccine willingness, COVID-19, pandemic health communication, evidence-based health messaging,
vaccine acceptance, vaccine hesitancy
INTRODUCTION
COVID-19, the disease caused by severe acute respiratory virus 2 (SARS-CoV-2), has demonstrated
capabilities of rapid transmission across populations [1]. First reported in 2019, more than 2.4
million deaths and upward of 117 million cases have been attributed to the virus as of March 2021
worldwide [2]. There have been extensive challenges in responding to the COVID-19 pandemic due
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to a lack of knowledge of the natural history of the disease profiles
it produces as well as rampant misinformation, skepticism and
conspiracies related to the virus and its mitigation efforts [3, 4].
In November 2020, Switzerland had among the highest
laboratory-confirmed COVID-19 cases per capita in the world
[5]. Young people aged 20 to 29 in Switzerland had the highest
infection rates across all age groups, posing a considerable threat
to vulnerable populations [5]. Although younger people are less
likely to experience serious negative health outcomes as a result of
a COVID-19 infection, their tendency toward greater frequency
of social interactions made them an essential group to consider in
controlling the spread of the virus [6–10]. In December 2020,
vaccine variants started to become available. As of March 2021,
Switzerland had not completed vaccinations of the eldest and
most at-risk groups of the population or published strategies to
vaccinate the rest of the population, including young people [11].
Thus, it is urgent to better understand vaccine hesitancy among
young adults as they are important disease vectors to address in
order to mount an effective immunization campaign [12–15]. It
remains unclear whether COVID-19 vaccination limits further
transmission, however, it is understood to protect vulnerable
populations. According to the Strategic Advisory Group of
Experts (SAGE) on Immunization, vaccine hesitancy is a
behavior influenced by a number of factors including issues of
confidence (trust in vaccine provider), complacency (perceptions
of need and/or value of a vaccine), and convenience (access) [16].
Switzerland has among the lowest levels of vaccine confidence
internationally [17]. In Switzerland, vaccinations are not
compulsory and a national vaccination registry does not exist
[18, 19]. This strategy was designed to provide autonomy in local
governance but has led to suboptimal vaccine coverage among the
general population [18, 20]. Coverage between cantons is
variable, for example, measles vaccination coverage is lower in
German- (71.3%) than French-speaking (85.0%) cantons [21].
Similarly, individuals in French-speaking cantons report greater
influenza vaccine coverage than those in German-speaking
cantons across all age groups [22]. Vaccine hesitancy and
refusal leads to under-immunization, reduction in potential for
reaching herd immunity, and increases the risk of preventable
illness and mortality. The success of mitigating outbreaks is
dependent on the public’s willingness to engage with
preventive public health programs including immunization.
Reasons for accepting or declining preventive measures in
pandemic situations include uncertainties of the severity of a
disease agent, perceptions that vaccines are rushed to market,
among others [23–27]. Emerging work on COVID-19 vaccine
acceptance demonstrates that these attitudes are highly variable
worldwide. Among European populations, approximately 7 in 10
(73.9%) reported a willingness to get vaccinated against COVID-
19 in early April 2020 [28]. Over time, vaccine acceptance has
been reported to be as low as 53.7% in Italy and as high as 80% in
Denmark according to more recent data [27, 29, 30]. Decreases in
vaccine acceptance were observed in Europe throughout the
pandemic which is thought to be associated with lower
perceived confidence in vaccine safety and effectiveness among
populations [29]. Public perceptions of vaccines in Switzerland
are poorly understood; existing research suggests a great influence
of local socio-cultural contexts as determinants of vaccination
decisions which may be distinct by Swiss region [31, 32]. More
recent public opinion polls and peer-reviewed literature from
around the world have noted a decreased willingness. For
example, among adults in the United Kingdom and
United States, approximately half responded that they would
likely get vaccinated; in Switzerland, only 16% had the same
response [3, 33–35]. These attitudes are not fixed and may change
as nations report on successes.
Young people form risk perceptions related to health issues, in
part, based on their perceptions of susceptibility and seriousness
of a particular disease as well as social patterning from respected
peers’ behavior [36]. Higher participation in immunization
programs may occur when individuals believe that effective
protections exist and when they are directed or enabled to
engage in such activities [37]. Young people may base
personal vaccine uptake decisions on misinformed or
shortsighted heuristics whereby they perceive the side-effects
related to a vaccine to be more likely than the disease it may
prevent [38, 39]. These perceptions are informed by their physical
and social environment which includes mass public health
information campaigns. Successful campaigns create enabling
conditions to seek reliable information on prevention and
other services to help mitigate a diseased state. For example,
human papilloma virus (HPV) vaccination rates among
adolescent young Swiss women aged 16 years were 51% if they
attended schools with a vaccination program and 37% if their
school did not have such a program [39]. In Switzerland, there
have been limited public attempts to actively engage and educate
young people about their role in combatting the COVID-19
pandemic. The most high profile appeal for limiting social
contact among young people came from the WHO in March
2020 [40]. It is unclear if and how this message was disseminated
or tailored to young people in Switzerland. In the absence of
reliable information campaigns, young adults may turn to the
internet as a primary source of information about COVID-19
where there is little information quality control [41]. Scientific
journals, media outlets and other respected sources of
information were not immune to baseless claims during this
pandemic, including conspiracy theories related to COVID-19
vaccine development and trials [42–48]. Perceptions of this media
landscape and their associations with vaccine uptake are currently
unknown among young people living in Switzerland in the
context of the COVID-19 pandemic.
Sociodemographic characteristics have been observed to
influence behavior and shape differences in cultural norms
around vaccine uptake. For example, women tend to be more
averse to vaccine uptake than males [49, 50]. Existing literature
suggests differences in immune responses between the sexes,
however, sex is not considered in the design or dosing of
recommended immunizations, which may lead to
undocumented adverse effects disproportionately affecting
females [51]. Women also report more influenza vaccination
concerns in terms of its efficacy and safety, and report more
adverse reactions to vaccines in general which may explain their
relatively lower uptake than men and greater hesitancy to
participate in immunization programs [49, 50]. Higher
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education has also been associated with increased uptake of
vaccines over the life course [52]. Differences in national
background have been observed in vaccine willingness in
Switzerland; non-Swiss children have higher vaccine coverage
levels than Swiss children [53]. Relatively greater household
economic resources has also been observed to affect
vaccination attitudes and behaviors although this has been a
confounder in some studies [32, 54].
To optimize COVID-19 vaccine utility, it is essential that
national health authorities have an evidence base to inform the
(re)allocation of resources to key and strategic subpopulations
and to develop strategies to combat deficiencies in health literacy
related to the COVID-19 pandemic. These activities should
include the development of mass communication campaigns
related to vaccination and clarifications of prevalent
misinformation.
The current prospective, community-based study took place in
Switzerland’s largest city, Zurich, over the course of the first
6 months of the COVID-19 outbreak in Europe and collected
data specific to young people’s perceptions of the COVID-19
virus and their opinions on a hypothetical vaccine compliance
strategy implemented by the Swiss government. The study sought
to characterize its respondents along sociodemographic factors
and provide perspectives important to the development of an
evidence base for Swiss-specific pandemic responses targeting
young people.
We expect that H1: there will be significant associations
between female sex and lower vaccine willingness, H2:
significant associations between perceptions of a favorable
government response and media coverage and vaccine
willingness, and that H3: experience with COVID-19 will be




Data came from a supplement to the Zurich Project on the Social
Development from Childhood to Adulthood (z-proso), an
ongoing prospective longitudinal study on the development of
prosocial and problem behavior (e.g., antisocial behavior) from
childhood to adulthood. A total of eight waves of data, at ages 7, 8,
9, 11, 13, 15, 17, and 20, were collected from children who, in
2004, entered first grade in one of 56 public primary schools in
Zurich. Stratified random sampling procedures used in the initial
target sample of schools oversampled less resourced school
districts. Details on original sample selection and attrition
have been detailed elsewhere [55, 56]. Respondents who had
participated in the age-20 assessment (2018, N  1,180) were
invited to participate in four data collections after Switzerland
went into its first home semi-confinement period which were
conducted in German: Supplement 1 (8–14 April 2020, N  786),
Supplement 2 (30 April–5 May 2020, N  650), Supplement 3
(21–26 May 2020,N  569), and Supplement 4 (10–15 September
2020, N  525). The current analyses primarily use data from
Supplement 4, when data on vaccination willingness was
collected, as well as assessments from ages 13 and 15 when
the most complete records for socioeconomic indicators were
collected.
At ages 13 and 15, participants completed a paper
questionnaire in classrooms outside of regular class times. At
age 20, the questionnaire was conducted on a computer at a
Decision Science Laboratory of the Swiss Federal Institute of
Technology (ETH) in Zurich which typically lasted 90 min. At
ages 13 and 15, respondents were compensated with 50 Swiss
Francs for their time. Those who had participated in the age-20
z-proso data collection were invited by SMS and e-mail to
participate in the supplementary COVID-19 data collection
through a personalized link. Respondents of the z-proso
COVID-19 Supplements, 1–4, were entered into a lottery with
the opportunity to win one of 50 prizes of 100 Swiss Francs each.
At each of the four Supplement waves, participants were given
7 days to complete the survey. The study was reviewed by and
received ethics clearance from the Ethics Committee of the
Faculty of Arts and Social Sciences of the University of Zurich.
Measures
Sociodemographic variables included: sex (female, male),
education level (compulsory school, vocational/technical
training, higher education), and household International
Socio-Economic Index of Occupational Status (ISEI) Quartile
at age 13/15 [57]. Preliminary analyses of the data revealed no
significant differences between respondents with Swiss or
Northwestern European maternal backgrounds; therefore, we
coded these participants into one Western European group.
Thus, categories presented include: Western European,
Southern European, Sri Lankan, Middle East and African, and
American and other maternal background.
Perceptions of Swiss authorities ‘response, politicians’ views,
andmedia coveragewere assessed with the following question and
statements: “What are your opinions and attitudes toward the
measures against the coronavirus? How much truth do the
following statements have for you?”; “The measures taken by
the Swiss authorities to deal with the coronavirus are effective.”; “I
agree with the measures taken by the Swiss authorities to combat
the coronavirus”; “Politicians and the media exaggerate the
threat”; “The media provides balanced and objective
information about the coronavirus.” Answer options included:
1 Not true at all, 2 Not really true, 3  Somewhat true, and 4 
Completely true; these were dichotomized to: 0  Not true at all/
not really true, and 1  Somewhat true/completely true.
Personal health experiences with COVID-19. Exposure of a
family member, partner, or other close person to COVID-19 was
assessed with the probe, “A family member, partner or other close
person. . .” where 1  has tested positive for COVID-19, but did
not have to go to the hospital because of it, 2  is/was sick with
COVID-19 and therefore had to go to the hospital, 3  died as a
result of the coronavirus illness. Each of these three items had
answer options 1  Yes, 2 No. A positive indication to any of the
three items probed across the four waves of data collection that
occurred during the pandemic was coded as: 0  Family member,
partner or related person’s health not affected by COVID-19,
alternatively 1  Family member, partner or related person’s
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health affected by COVID-19 if there were positive responses to
the probes. Next, a respondent’s personal health affected by the
COVID-19 was assessed using the probe, “I myself. . .” where 1 
had symptoms that could be attributed to the coronavirus with
answer options 1  Yes, 2  No. If respondents indicated a
positive response to the probe in any of the four data collection
waves that were conducted during the pandemic, they were coded
as 1  Personal health affected by COVID-19 pandemic, 0 
Personal health not affected by the COVID-19 pandemic.
Initially, Swiss authorities established regulations that barred
asymptomatic and subclinical suspected cases from testing which
is the most common presentation of a COVID-19 infection among
young people, thus, self-reported data may provide a better estimate
of prevalence of disease among this population [58].
Attitudes toward vaccination were assessed with the following
hypothetical: “Imagine that Switzerland has officially approved a
vaccine against the coronavirus.” “Would you get vaccinated?”;
answer options: 1  Yes, for sure, 2  Yes, probably, 3 
Undecided, 4  No, probably not, and 5  Definitely not. A
binary variable was created to assess respondents’ reported
likelihood of getting vaccinated coded as 1  Likely to get
vaccinated and 0  Not likely to get vaccinated or undecided
should a vaccine become available. Delving deeper, undecided
about vaccination was coded as 1  Undecided and 0  Decided
either way. Participants were also asked, “Would you agree to an
obligatory vaccination if the public health authorities mandated
it?” with answer options, 1  Completely agree, 2  Somewhat
agree, 3  Somewhat disagree, and 4  Completely disagree. To
assess whether respondents would be agreeable to a mandatory
vaccine, a binary variable was created coded as 1  Agree and 0 
Disagree.
Analysis
All analyses were conducted using SPSS (Version 26.0, Armonk,
NY: IBM Corp.). Survey weights were used to allow for
generalization back to the original recruitment population (see
Nivette et al. 2021). Logistic regression models examined whether
personal and peripheral experiences with COVID-19 and
perceptions of the Swiss government response and media
portrayal of the pandemic were associated with attitudes
toward vaccination including likelihood of vaccine uptake,
being undecided about vaccination, and agreeableness to a
compulsory vaccination. Final models included sex, maternal
national background, respondents’ education level, household
ISEI quartile, perceptions of governmental response, perceptions
of media portrayal of the pandemic, and personal experiences
with COVID-19. Sample weights were applied to all analyses.
RESULTS
Sample characteristics are displayed in Table 1. Overall, 525
respondents completed the fourth z-proso COVID-19
supplement survey which included the questions on
vaccination. However, respondents who reported being outside
of Switzerland at the time that the survey was administered were
excluded; hence the analytic sample of 499. Perceptions of Swiss
authorities’ response, politicians’ views, and media coverage are
presented in Figure 1.
Vaccination Willingness
Table 2 shows that approximately half (46.9%) of young people
surveyed reported that they would likely get vaccinated if a
vaccine became available. Final adjusted logistic regression
analyses indicated that females were less likely than males to
indicate vaccination willingness (p < 0.001, OR  0.46, 95%CI 
0.30–0.71). Respondents with a Sri Lankan maternal background
were more likely to report that they would get vaccinated than
respondents of other cultural backgrounds (p < 0.01); this Sri
Lankan maternal background became significant and stronger
from the bivariate models (Table A1) to the adjusted models (in
Table 2), with the adjustment of socioeconomic status. Thus,
when SES is held equal, participants with a Sri Lankan
background are more likely to report a higher likelihood of
getting vaccinated. Lower educational attainment was
associated with lower likelihood of vaccine willingness.
Individuals with vocational or technical training were less
likely to report vaccine willingness than those with higher
education (p  0.015, OR  0.55, 95%CI  0.34–0.89).
Compared to respondents in the lowest ISEI quartile, all
others were more likely to be willing to get vaccinated against
COVID-19 (p < 0.01).
Table 3 shows that respondents who perceived that the
Swiss national response was effective and that politicians
provided non-exaggerated views of the COVID-19 situation
were more likely to report a greater likelihood of getting
vaccinated than those who reported otherwise (p  0.048,
OR  1.64, 95%CI  1.00–2.68 and p < 0.001, OR  3.93,
95%CI  2.49–6.21 respectively). Finally, personal experience
with COVID-19 was not significantly associated with greater
likelihood of vaccination willingness. One exception was that
respondents whose own health and the health of close ones was
reportedly affected by COVID-19 were less likely to report
vaccination willingness than when only they themselves had
been affected (p  0.026, OR  0.49, 0.26–0.92).
Undecided About Vaccination
A significant minority of respondents, approximately 1 in 5
(19.9%), reported being undecided about getting vaccinated.
Table 3 shows that female respondents were more likely to be
undecided than males (p  0.039, OR  1.66, 95%CI 
1.03–2.67). In final adjusted models, Sri Lankans were less
likely than those with Western European backgrounds to
report being undecided about vaccination (p  0.029, OR 
0.18, 95%CI  0.04–0.84). Conversely, Southern Europeans
were much more likely to report being undecided than those
with Sri Lankan backgrounds (p  0.016, OR  6.89, 95%CI 
1.44–32.97). Respondents in the top two socioeconomic
quartiles (Q3 and Q4) were less likely to be undecided than
those in the lowest quartile (p  0.011, OR  0.41, 95%CI 
0.21–0.82 and p  0.017, OR  0.40, 95%CI  0.19–0.85
respectively). Finally, those who believed that the Swiss
government had responded effectively were less likely to be
undecided (p  0.021, OR  0.53, 95%CI  0.31–0.91).
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TABLE 1 | Sample characteristics; Zurich Project on the Social Development from Childhood to Adulthood, Zurich, Switzerland, September 2020.
Sample characteristics Unweighted (N = 498) Weighted (N = 499)
n % %
Sex Female 300 60.2 47.7
Male 198 39.8 52.3
Maternal Country of Birth
Western Europe 303 60.8 52.6
Southern Europe 69 13.9 21.7
Sri Lanka 26 5.2 5.4
Middle East and Africa 68 13.7 12.6
American and Other 28 5.6 7.0
Highest Education Attained, Age 20
Compulsory School 50 10.0 10.4
Vocational/Technical Training 273 54.8 58.0
Higher Education 175 35.1 31.6
International Socio-economic Index of Occupational Strata
Lowest 25% 112 22.5 28.1
Q2 127 25.5 24.7
Q3 127 25.5 22.8
Highest 25% 122 24.5 22.1
Perceptions of Swiss Government Response, Fall 2020
Effective 305 61.2 59.4
Agrees with response 359 72.1 69.9
Perceptions of theMedia’s and Politicians’ Views of COVID-19,
Fall 2020
Not exaggerated 271 54.4 52.0
Perceptions of Media Coverage, Fall 2020
Balanced and objective 245 49.2 49.6
Personal health experiences with COVID-19, April—September 2020
Personal health and health of close person(s)aunaffected 211 42.4 42.5
Personal health and health of close person(s)aaffected 90 18.1 18.4
Only health of close person(s)aaffected 76 15.3 15.2
Only personal health affected 121 24.3 24.0
Note: Western Europe: Switzerland, Italy, Portugal, Spain, Germany, European Union 15 Member States/European Free Trade Association; Southern Europe: Serbia/Montenegro/
Kosovo, Bosnia-Herzegovina, Croatia, Macedonia, South and East Europe; Middle East and Africa: North Africa, Sub-Saharan Africa, Near East, Middle and Far East, Turkey; Americas
and Other: United States of America, Canada, New Zealand, Australia, Brazil, Other Latin America, Other.
aClose person(s): include family member, partner, or related person.
FIGURE 1 | Perceptions of Swiss authorities ‘response, politicians’ views, andmedia coverage (N  499); Zurich Project on the Social Development fromChildhood
to Adulthood, Zurich, Switzerland, September 2020.
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Agreement to Compulsory Vaccination
When asked about their opinion on a situation whereby the
authorities implemented a compulsory vaccination mandate,
approximately half (45.9%) of young people surveyed were
agreeable to this strategy. However, female respondents were
less likely to agree than males (p  0.002, OR  0.52, 95%CI 
0.35–0.79). Respondents with a maternal Sri Lankan background
were more likely to agree than those who identified any other
national background (p < 0.05). Differences in responses by ISEI
were limited to those in Q2 being less likely than those in the
highest ISEI quartile to agree to such a mandate (p  0.016, OR 
0.48, 95%CI  0.26–0.87). Finally, when respondents perceived
that politicians provided non-exaggerated views and that the
media provided fair and balanced coverage of the pandemic,
they were more likely to agree to compulsory, health authority-
mandated vaccinations (p < 0.001, OR  2.59, 95%CI  1.68–3.99
and p  0.001, OR  2.01, 95%CI  1.32–3.08).
DISCUSSION
In September 2020, before any COVID-19 vaccine was approved
worldwide, almost half of young adults in Zurich were either
undecided or unlikely to get vaccinated against COVID-19 and
also would not agree with coercive vaccine mandates. This is
generally consistent with recent Swiss general population surveys,
which reported that COVID-19 vaccine willingness has eroded as
the pandemic and social restrictions have been prolonged [34,
59]. These low rates of vaccine willingness among youth and
young adults is concerning; their cooperation with mitigation
efforts such as vaccinations are essential to combatting COVID-
19 at a national level [5]. To date, no information campaigns have
yet been tailored to or systematically deployed specifically to
young people in Swiss settings that expound on their importance
to COVID-19 eradication efforts and the collective interest in
their participation in immunization programs.
Historically, vaccination rates in Switzerland have not always
been high enough to protect the population (18). Arguably, parts
of the population do not sufficiently endorse vaccines as an
acceptable and effective strategy to prevent disease or
mortality. Coercive immunization programs in certain
countries have proven to be effective in reducing morbidity
and mortality of vaccine preventable diseases, however, they
are ethically fraught, and may lead to further resistance [60,
61]. Switzerland values plurality and policy diversity among its
different cantons; this is reflected in the cantons’ different
immunization programs and outcomes. Deficiencies in vaccine
compliance among cantons have been attributed to differing
priorities and practices of policy makers and attitudes of
vaccine gate-keepers (e.g., nurses, general practitioners) and
engagement in alternative health care and education
pedagogies [32, 53, 62]. Swiss communities report an openness
to public programs if their autonomous decision-making is
respected [62–66].
The findings of the current study suggest that in Fall 2020,
young women in Switzerland were less willing to get vaccinated
against COVID-19, more undecided about vaccination, and
unlikely to agree to a mandatory vaccine. These findings are
consistent with existing research on sex differences in vaccine
acceptance and uptake.
In final adjusted models, Sri Lankan maternal background was
associated with greater vaccination willingness, lower vaccine
undecidedness, and more agreement to mandated immunization
than all other national groups in the sample. These findings only
emerged when socioeconomic background, which is a
considerable social determinant of health and health behaviors,
was adjusted for. Sri Lanka has vaccine coverage approaching
99% for most vaccine-preventable diseases [67]; thus, young
adults with a Sri Lankan background may have stronger
cultural norms of participating in vaccination programs
compared to young adults from other nationalities with
comparable socioeconomic status [68].
Young adults in the current study in higher ISEI quartiles were
more likely to report vaccine willingness and being decided about
vaccination. In other studies, socioeconomic status has been a
confounder to vaccine willingness, as it has been associated with
TABLE 2 | Attitudes toward a COVID-19 vaccination among young people in; Zurich Project on the Social Development from Childhood to Adulthood, Zurich, Switzerland,
September 2020.
Q. Imagine that Switzerland has officially approved a vaccination against the coronavirus
Unweighted (n = 496) Weighted (n = 497)
N % %
Would you get vaccinated?
Yes, for sure 102 20.5 19.5
Yes, probably 140 28.1 27.4
Undecided 97 19.5 19.9
No, probably not 79 15.9 16.9
No, definitely not 78 15.7 16.0
Unweighted (n  495) Weighted (n  495)
Opinion on authorities making vaccine mandatory n % %
Totally agree 83 16.7 17.0
Somewhat agree 145 29.1 28.9
Somewhat disagree 134 26.9 26.0
Disagree completely 133 26.7 27.5
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greater likelihood of an acceptance of alternative medicines that
are not based on a biomedical model of health [69]. Future studies
should continue to untangle the mechanisms that drive these
alternative attitudes in order to identify intervention points that
optimize local public health strategy.
Finally, the current study provides concrete evidence that
while the population of young adults in Switzerland does not
necessarily have to agree with the extraordinary measures that the
Swiss government took in order to perceive that the national
response was effective. When presented with what young people
perceive to be balanced views from politicians, decision makers,
and media, young adults are more open to participating in
immunization programs and become more open to
paternalistic strategies to mitigate the spread of COVID-19.
These findings provide an evidence base on which to build
mass information campaigns dedicated to subpopulations of
young adults that adequately inform and build resilience
against misinformation that may otherwise dissuade them
TABLE 3 |Multivariate logistic regression analyses examining likelihood of getting vaccinated, vaccine hesitancy, and opinion to compulsory vaccination, weighted analyses;
Zurich Project on the Social Development from Childhood to Adulthood, Zurich, Switzerland, September 2020.
Characteristic Ref.
Category







p OR 95%CI p OR 95%CI p OR 95%CI
Sex
Female Male <0.001 0.46 0.30–0.71 0.039 1.66 1.03–2.67 0.002 0.52 0.35–0.79
Maternal Country of Birth
Southern Europe Western Europe 0.472 0.81 0.45–1.45 0.478 1.24 0.68–2.27 0.951 1.02 0.58–1.79
Sri Lanka 0.005 4.26 1.56–11.66 0.029 0.18 0.04–0.84 0.007 4.01 1.45–11.07
Middle East and Africa 0.913 0.96 0.49–1.90 0.422 0.74 0.36–1.54 0.458 1.27 0.67–2.41
Americas and Other 0.582 0.79 0.33–1.86 0.841 0.91 0.35–2.38 0.706 0.85 0.36–1.99
Southern Europe Americas and Other 0.956 1.03 0.39–2.73 0.556 1.37 0.48–3.94 0.708 1.20 0.46–3.10
Sri Lanka 0.009 5.43 1.54–19.14 0.072 0.20 0.03–1.16 0.016 4.73 1.34–16.67
Middle East and Africa 0.693 1.23 0.44–3.40 0.723 0.82 0.27–2.49 0.418 1.50 0.56–4.00
Southern Europe Sri Lanka 0.002 0.19 0.07–0.54 0.016 6.89 1.44–32.97 0.011 0.25 0.09–0.73
Middle East and Africa 0.008 0.23 0.08–0.68 0.084 4.10 0.83–20.36 0.039 0.32 0.11–0.95
Southern Europe Middle East and Africa 0.656 0.84 0.38–1.83 0.211 1.68 0.75–3.78 0.549 0.80 0.38–1.66
Highest Education Attained, Age 20
Vocational/Technical Training Compulsory Schooling 0.829 0.93 0.46–1.87 0.467 1.37 0.59–3.15 0.901 1.05 0.53–2.08
Higher Education 0.173 1.69 0.79–3.60 0.377 1.51 0.61–3.75 0.218 1.59 0.76–3.35
Vocational/Technical Training Higher Education 0.015 0.55 0.34–0.89 0.730 0.91 0.52–1.59 0.082 0.66 0.41–1.06
International Socio-economic Index of Occupational Strata
Q2 Lowest 25% 0.033 1.93 1.06–3.53 0.067 0.56 0.31–1.04 0.205 0.69 0.39–1.22
Q3 0.007 2.39 1.27–4.52 0.011 0.41 0.21–0.82 0.758 0.91 0.50–1.66
Highest 25% 0.003 2.76 1.40–5.44 0.017 0.40 0.19–0.85 0.262 1.45 0.76–2.76
Q2 Highest 25% 0.255 0.70 0.38–1.29 0.351 1.41 0.69–2.89 0.016 0.48 0.26–0.87
Q3 0.637 0.87 0.48–1.56 0.942 1.03 0.51–2.07 0.107 0.63 0.36–1.11
Q3 Q2 0.464 1.24 0.70–2.20 0.346 0.73 0.38–1.41 0.341 1.32 0.75–2.32
Perceptions of Swiss Government Response to COVID-19 pandemic, Fall 2020
Effective Not effective 0.048 1.64 1.00–2.68 0.021 0.53 0.31–0.91 0.400 1.23 0.76–1.97
Agrees to measures taken Does not agree 0.795 1.07 0.63–1.85 0.083 1.70 0.93–3.10 0.317 1.31 0.77–2.22
Perceptions of Media and Politicians’ views of COVID-19, Fall 2020
Non-exaggerated views Exaggerated views <0.001 3.93 2.49–6.21 0.306 0.77 0.46–1.28 <0.001 2.59 1.68–3.99
Perceptions of Media Coverage, Fall 2020
Fair and Balanced Not fair or balanced 0.062 1.53 0.98–2.38 0.887 0.96 0.58–1.60 0.001 2.01 1.32–3.08
Personal health experiences with COVID-19, April—September 2020
Personal health and health of close
person(s) affected
Personal health and close
person(s) unaffected
0.258 0.72 0.41–1.27 0.162 1.54 0.84–2.90 0.479 1.22 0.70–2.11
Only health of close person(s)
affected
0.621 1.17 0.63–2.15 0.993 1.00 0.51–1.96 0.074 1.71 0.95–3.06
Only personal health affected 0.142 1.48 0.88–2.50 0.754 1.10 0.61–1.98 0.331 1.28 0.78–2.13
Personal health and health of close
person(s) affected
Only personal health affected 0.026 0.49 0.26–0.92 0.336 1.40 0.71–2.76 0.869 0.95 0.52–1.75
Only health of close person(s)
affected
0.483 0.79 0.40–1.54 0.799 0.91 0.43–1.91 0.385 1.33 0.70–2.52
Only health of close person(s)
affected
Personal health and health of close
person(s) affected
0.621 1.17 0.63–2.15 0.993 1.00 0.51–1.96 0.074 1.71 0.95–3.06
Note: Western Europe: Switzerland, Italy, Portugal, Spain, Germany, European Union 15 Member States/European Free Trade Association; Southern Europe: Serbia/Montenegro/
Kosovo, Bosnia-Herzegovina, Croatia, Macedonia, South and East Europe; Middle East and Africa: North Africa, Sub-Saharan Africa, Near East, Middle and Far East, Turkey; Americas
and Other: United States of America, Canada, New Zealand, Australia, Brazil, Other Latin America, Other.
aClose person(s): include family member, partner, or related person.
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from immunization efforts. Furthermore, it identifies women,
those with relatively lower educational achievement, and
socioeconomically disadvantaged groups as priorities for
immunization information campaigns. Any public health
effort should tailor messaging that is relevant to the target
group, contains clear guidelines, and is easily understandable to
improve health literacy specific to COVID-19 or any other
contagion. When information is too complex, it fails to lead to
disambiguation, increases feelings of despair and panic, and
further confuses an already stressed population [70].
The current study used a broad and diverse sample that is
representative of young adults living in Zurich during the time of
the COVID-19 pandemic. While it may not be representative of
French- or Italian-speaking Switzerland, it provides a measure
that may be standardized that informs willingness to participate
in vaccination programs. The findings may be useful during times
of epidemics but also generally inform the Swiss National
Vaccination Strategy and related public health activities. The
substantial attrition across survey waves is a limitation mitigated
with the development and application of survey weights to reflect
the original sample in all analyses; it may have been further
mitigated with a longer data collection period. The original target
sample was generally representative of first-graders in Zurich in
2004. In the current study, we used sampling weights that allowed
us to generalize findings back to this original sample, which
consisted of a balanced sample of males and females. The use of
non-validated scales is a potential limitation, but also a necessity
during times of novel stressors for which we may not have well-
established scales. The current study identifies groups that may
have strong vaccine-adherence practices based on their national
background that should be leveraged to inform public health
practice in Swiss settings—specifically, factors that sustain and
maintain strong immunization compliance. Furthermore, we
emphasize the importance of including sex-based
considerations in vaccine messaging development and identify
populations that may be at risk of future immunization
deficiencies.
Overall, our findings suggest that approximately half of young
people living in Switzerland’s largest city report being unlikely to
participate in COVID-19 immunization programs. However,
when young adults perceived information in their media
landscape to be balanced and objective, they were more likely
to report a willingness to get vaccinated and even participate in a
health authority-mandated vaccination program. In order to
create and sustain these attitudes, targeted public information
campaigns relatable to young adults, delivered at an appropriate
language level that are easy to understand are essential to creating
enabling conditions for participation in improving immunization
coverage efforts.
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APPENDIX
TABLE A1 | Bivariate logistic regression analyses examining likelihood of getting vaccinated, vaccine hesitancy, and opinion to compulsory vaccination, weighted analyse;
Zurich Project on the Social Development from Childhood to Adulthood, Zurich, Switzerland, September 2020.
Likelihood of getting vaccinated Likelihood of being
undecided about getting
vaccinated
Likely to agree to compulsory
vaccine







Female Male 0.008 0.63 0.44 0.88 0.136 1.39 0.90 2.16 0.003 0.59 0.42 0.83
Maternal Country of Birth
Southern Europe Western Europe 0.008 0.53 0.33 0.85 0.203 1.43 0.82 2.48 0.254 0.76 0.48 1.22
Sri Lanka 0.451 1.37 0.60 3.12 0.357 0.56 0.16 1.93 0.043 2.43 1.03 5.76
Middle East and Africa 0.012 0.50 0.29 0.86 0.750 1.11 0.58 2.14 0.418 0.80 0.47 1.37
Americas and Other 0.040 0.45 0.21 0.96 0.982 0.99 0.39 2.51 0.144 0.57 0.26 1.21
Southern Europe Americas and Other 0.711 1.17 0.51 2.72 0.473 1.44 0.53 3.95 0.491 1.34 0.58 3.11
Sri Lanka 0.042 3.06 1.04 8.95 0.455 0.57 0.13 2.52 0.010 4.30 1.42 13.00
Middle East and Africa 0.816 1.11 0.46 2.68 0.830 1.12 0.39 3.26 0.432 1.42 0.59 3.40
Southern Europe Sri Lanka 0.036 0.38 0.16 0.94 0.155 2.56 0.70 9.31 0.014 0.31 0.12 0.79
Middle East and Africa 0.033 0.36 0.14 0.92 0.315 1.99 0.52 7.58 0.024 0.33 0.13 0.86
Southern Europe Middle East and Africa 0.869 1.06 0.55 2.02 0.513 1.29 0.61 2.73 0.865 0.95 0.50 1.79
Highest Education Attained, Age 20
Vocational/Technical Training Compulsory Schooling 0.005 2.46 1.32 4.59 0.609 1.25 0.54 2.89 0.056 1.83 0.98 3.39
Higher Education 0.441 0.79 0.44 1.43 0.275 1.56 0.70 3.48 0.559 0.84 0.46 1.51
Vocational/Technical Training Higher Education <0.001 0.32 0.22 0.47 0.341 1.25 0.79 2.00 <0.001 0.46 0.32 0.67
International Socio-economic Index of Occupational Strata
ISEI Highest 25% ISEI Lowest 25% <0.001 3.86 2.29 6.48 0.032 0.51 0.27 0.94 0.018 1.83 1.11 3.02
ISEI Q3 0.002 2.22 1.35 3.65 0.050 0.55 0.30 1.00 0.677 0.90 0.56 1.47
ISEI Q2 0.135 1.46 0.89 2.40 0.267 0.725 0.41 1.28 0.046 0.60 0.37 0.99
ISEI Q2 ISEI Highest 25% <0.001 0.38 0.23 0.63 0.273 1.43 0.75 2.72 <0.001 0.33 0.20 0.55
ISEI Q3 0.032 0.58 0.35 0.95 0.812 1.09 0.56 2.12 0.006 0.49 0.30 0.81
ISEI Q3 ISEI Q2 0.089 1.52 0.94 2.46 0.378 0.76 0.41 1.41 0.111 1.49 0.91 2.44
Perceptions of Swiss Government Response to COVID-19 pandemic—Effective, Fall 2020
Effective Not effective <0.001 1.97 1.38 2.81 0.103 0.70 0.46 1.08 0.011 1.58 1.11 2.25
Perceptions of Swiss Government Response to COVID-19 pandemic—Agrees to measures, Fall 2020
Agrees to measures taken Does not agree <0.001 2.38 1.61 3.52 0.854 1.05 0.65 1.67 <0.001 2.16 1.46 3.20
Perceptions of Politicians’ views of the COVID-19 pandemic—Exaggerated, Fall 2020
Non-Exaggerated views Exaggerated views <0.001 4.704 3.255 6.799 0.309 0.80 0.52 1.23 <0.001 3.72 2.59 5.34
Perceptions of media coverage, Fall 2020
Fair and Balanced Not fair or balanced <0.001 3.152 2.212 4.491 0.373 0.82 0.54 1.26 <0.001 3.56 2.49 5.10
Personal health experiences with COVID-19, April—September 2020
Only personal health affected Personal health and close
person(s) unaffected
0.074 1.49 0.96 2.31 0.762 1.09 0.63 1.89 0.209 1.32 0.86 2.05
Only health of close person(s)
affected
0.873 1.04 0.63 1.73 0.762 1.11 0.58 2.10 0.242 1.36 0.81 2.26
Personal health and health of
close person(s) affected
0.091 0.66 0.41 1.07 0.231 1.42 0.80 2.51 0.873 1.04 0.65 1.67




0.003 0.44 0.26 0.76 0.416 1.30 0.69 2.45 0.368 0.79 0.47 1.33
Only health of close person(s)
affected
0.210 0.70 0.40 1.22 0.969 1.01 0.50 2.04 0.931 1.03 0.59 1.79
Only health of close person(s)
affected
Personal health and health
of close person(s) affected
0.132 1.58 0.87 2.87 0.494 0.78 0.38 1.59 0.375 1.31 0.73 2.35
Note: Western Europe: Switzerland, Italy, Portugal, Spain, Germany, European Union15 Member States/European Free Trade Association; Southern Europe: Serbia/Montenegro/
Kosovo, Bosnia-Herzegovina, Croatia, Macedonia, South & East Europe; Middle East & Africa: North Africa, Sub-Saharan Africa, Near East, Middle & Far East, Turkey; Americas & Other:
United States of America, Canada, New Zealand, Australia, Brazil, Other Latin America, Other.
aClose person(s): include family member, partner, or related person.
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